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Abstract
Background: Differentiation of mesenchymal stem cells to osteoblasts is widely performed in research laboratories.
Classical tests to prove this differentiation employ procedures such as cell fixation, cell lysis or cell scraping. Very
few studies report gentle dissociation of mesenchymal stem cells undergoing an osteodifferentiation process. Here
we used this technique to reveal the presence of several cell layers during osteogenesis and to study their different
properties.
Methods: Through the sequential enzymatic detachment of the cells, we confirm the presence of several layers of
differentiated cells and we compare them in terms of enzymatic sensitivity for dissociation, expression of cluster of
differentiation, cytosolic calcium oscillations and osteogenic potential. Adipogenic and neurogenic differentiations
were also performed in order to compare the cell layers.
Results: The cells undergoing differentiation formed one layer in the neurogenic differentiation, two layers in the
adipogenic differentiation and at least four layers in the osteogenic differentiation. In the latter, the upper layers,
maintained by a collagen I extracellular matrix, can be dissociated using collagenase I, while the remaining lowest
layer, attached to the bottom of the dish, is sensitive only to trypsin-versene. The action of collagenase I is more
efficient before the mineralization of the extracellular matrix. The collagenase-sensitive and trypsin-sensitive layers
differ in their cluster of differentiation expression. The dissociation of the cells on day 15 reveals that cells could
resume their growth (increase in cell number) and rapidly differentiate again in osteoblasts, in 2 weeks (instead of 4
weeks). Cells from the upper layers displayed a higher mineralization.
Conclusions: MSCs undergoing osteogenic differentiation form several layers with distinct osteogenic properties.
This could allow the investigators to use upper layers to rapidly produce differentiated osteoblasts and the lowest
layer to continue growth and differentiation until an ulterior dissociation.
Keywords: Mesenchymal stem cells, Multilayers, Collagenase I, Trypsin, Extracellular matrix, Cluster of
differentiations, Calcium oscillations
Background
Mesenchymal stem cell (MSC) osteogenic differentiation
was the first differentiation to be identified by Friedenstein
et al. in the late 1960s–early 1970s [1, 2]. As the MSCs
(known then as marrow stromal cells) were extracted from
the bone marrow, it was not surprising that they could give
rise to osteoblasts. In vitro, osteogenic differentiation occurs
during a period of 1 month and produces differentiated os-
teoblasts. Downregulation of DNA replication by the sec-
ond week of differentiation is associated with expression of
osteoblast markers (such as alkaline phosphatase (ALP)),
processing of type I procollagen to collagen I under the ef-
fect of ascorbic acid, and progressive deposition of a collag-
enous extracellular matrix (ECM) [3]. Later on, other bone
markers can be detected, such as osteocalcin, osteopontin,
bone sialoprotein and osteonectin. Hydroxyapatite deposits
mark the final phase of osteoblast phenotypic development
[3]. The ECM is an essential element for the osteogenic
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differentiation; it is secreted by the MSCs undergoing
osteogenic differentiation and contains growth factors and
many proteins such as fibronectin, vitronectin, laminin,
osteopontin and osteonectin [4]. Osteoblasts must be in
contact with a collagen I matrix before they can differenti-
ate [5]. ECM formation is a marker of MSC differentiation
to osteoblast, and it accumulates maximally after 1 week of
culture. After 2 weeks of culture, mineralization of ECM
begins, which marks the final phase of the osteoblast
phenotypic development [3]. Cell proliferation before
mineralization is a critical process for increasing bone mass.
Because the cells are exposed to the differentiating agents
when they form a more or less confluent monolayer in the
culture dishes, the differentiated cells in 2D cultures are
sometimes referred to as “monolayers” [6], “confluent
monolayers” [7] or “cells in monolayers” [8]. The term
“multilayer” was barely used [9]. Zhu et al. [10] showed that
weak osteogenesis is characterized by the formation of an
ALP-positive cell monolayer while strong osteogenesis is
characterized by the presence of multilayered ALP-positive
nodular structures. To assess the differentiation potential,
the investigators used many classical tests that label the
cells or measure the osteogenic markers. In all of these
methods, there was no dissociation of the cells from the dif-
ferent layers. Indeed, the first step is often the fixation of
the cells, for example to stain the cells with Alizarin Red
that labels the deposits of calcium phosphate (hydroxyapa-
tite Ca5(PO4)3(OH)) [11, 12]. Other tests such as immuno-
fluorescent labeling [13, 14], ECM protein production [4]
and external ALP measurement [12, 15] are performed
without dissociation of the cells, just after their fixation. In
other methods, the supernatant of the cells is taken to
measure osteocalcin [6, 16], type I procollagen [16], bone
sialoprotein or different specific cytokine production [17,
18] by ELISA or other techniques. Finally, other methods
start with the scraping or the lysis of the cells using
trichloroacetic acid and SDS [9], sonication [16], trizol [19],
RIPA buffer [17] or many freeze–thaw cycles [15] in order
to perform DNA and calcium assays [16, 20, 21], to meas-
ure internal ALP by colorimetric assays [14, 15, 17, 21, 22]
or to detect specific proteins by western blot analysis or
mRNA by RT-PCR [6, 8, 9, 12]. None of these techniques
dissociated the living cells. Some studies [14, 23] used tryp-
sin alone (until day 14 of osteodifferentiation, before the
mineralization occurred) or trypsin–EDTA [24, 25] to har-
vest all of the layers in 2D cultures.
In our study, we used human adipose mesenchymal
stem cells (haMSCs) to perform osteogenic, adipogenic
and neurogenic differentiations to assess the multipo-
tency of the haMSCs and to compare the evolution of
the cells in one or several layers during the differenti-
ation. Confocal microscopy observations were performed
in order to assess the evolution of the cells in one or
many layers in the three differentiations. Furthermore,
differential dissociation by collagenase I and trypsin was
performed on the layers in osteogenic differentiation.
The different layers were then characterized by their
cluster of differentiation markers and their Ca2+ oscilla-
tions in order to evaluate whether they were identical or
not. The different cell populations resulting from differ-
ential dissociation at day 15 were also cultivated separ-
ately to evaluate their osteogenic potential. This study
presents new observations on the cell layers in an
in-vitro osteogenic differentiation and proposes a new
method to dissociate the cells, which could expand their
use and facilitate applications.
Methods
Cell culture and differentiation
haMSCs were isolated from surgical waste of individuals
undergoing elective lipoaspiration. The cells were grown
in Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10% foetal bovine serum, 100 U/ml penicil-
lin and 100 mg/ml streptomycin, and were cultured at
37 °C in a humidified incubator with 5% CO2. Cells were
passed twice a week (every passage corresponded to one
doubling time of the population). The multipotency cap-
abilities of the cells were assessed by submitting them to dif-
ferentiation conditions as previously reported by Liew et al.
[26]. The cell culture chemicals were purchased from Fischer
Scientific (Parc d’innovation, Illkirch, France). Prior to every
differentiation, cells were seeded at a density of 15,000 cells/
cm2 and left in culture for 2–3 days to attain confluence,
after which the normal medium was removed and differenti-
ation medium was added. This medium change corre-
sponded to differentiation day 1. The osteogenic medium
was composed of complete alpha MEM supplemented with
100 nM of dexamethasone, 200 μM of ascorbic acid and
10 mM of glycerol 2-phosphate. The medium was changed
twice a week. For the adipogenic differentiation, two media
were consecutively used: an induction medium composed of
complete DMEM supplemented with 1 μM dexamethasone,
200 μM indomethacin, 500 μM 3-isobutyl-1-methylxantine
and 10 μg/ml insulin for 2–3 days; and a maintenance
medium composed of complete DMEM supplemented with
10 μg/ml insulin renewed every 24 h. For the neurogenic dif-
ferentiation, a ready-to-use neurogenic induction medium
was used from Promocell (C-28015), and was changed every
48 h. The controls were haMSCs cultivated without passage
in their normal medium, which was changed twice a week.
Cell dissociation and counting
In adipogenic differentiation and neurogenic differenti-
ation, cells were simply trypsinized and counted three
times at every time point (days 1, 8, 15, 22 and 29). As
described in this article, several layers of cells could be
distinguished in osteogenic differentiation. To dissociate
the upper layers before the calcium deposits begun to
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appear, 2 mg/ml collagenase I (Fisher Scientific, Illkirch,
France) diluted in PBS was added to the cells for
30 min. After collagenase I action, the cell cultures were
pipetted gently to remove all cells of the upper layers.
The remaining layer was trypsinized. When the
mineralization occurred (i.e. when Ca2+ deposits became
apparent), the calcium deposits were removed using 20–
40 mM of EDTA in PBS for 20–40 min, depending on
the density of these deposits. The cells of the upper
layers were then detached using a higher concentration
of collagenase (4 mg/ml) and the cells of the lowest layer
using trypsin. The cells from all the layers were gathered
together in one tube and counted three times at every
time point.
Alkaline phosphatase assay and Alizarin Red staining
In order to test the ALP activity (osteogenic differenti-
ation), cells were harvested using collagenase I and tryp-
sin, centrifuged at 1500 rpm for 5 min, resuspended in
1 ml of cold PBS (4 °C) and counted. A volume corre-
sponding to 300,000 cells was taken, centrifuged and
suspended in 600 μl of assay buffer (Abcam), and centri-
fuged at 13,200 rpm for 5 min at 4 °C. The supernatant
was transferred to a new tube. Then 200 μl of the super-
natant was distributed in four wells of a 96-well plate
(50 μl/well). One of these wells served to determine the
background through the simultaneous addition of 80 μl
p-nitrophenyl phosphate (pNPP) 1 mM and 20 μl of stop
solution. For the three remaining wells, 80 μl of pNPP
was added. After 60 min, 20 μl of stop solution (Abcam)
was added to the wells and the plate was read in a spec-
trophotometer (BioTek, Colmar, France) to measure the
optical density at 405 nm. The quantity of p-nitrophenol
(pNP) in each well was determined using a standard
curve established using pNPP and purified ALP enzyme.
Then 350 μl of the remaining supernatant was incubated
with 750 nM of Hoechst 33342 for 30 min and distrib-
uted in triplicate in an opaque 96-well plate to read the
fluorescence at 365 nm excitation. Prior to Alizarin Red
staining, cells were washed in PBS and fixed in 95%
methanol for 10 min. Alizarin Red S solution 2% was
added for 5 min, then rinsed with water and imaged
under an epifluorescence microscope to visualize the
Ca2+ deposits. To quantify the Alizarin Red staining,
10% cetylperidinium chloride (Sigma Aldrich) was added
(1 ml for 10 cm2) and cells were incubated for 20 min to
elute the stain. Alizarin Red staining was then quantified
by measuring the absorbance of the eluted stain at
570 nm using a spectrophotometer and normalizing by
the number of cells.
FABP4 and Bodipy staining
To assess adipogenic differentiation, the attached cells
were washed after medium removal, fixed in 10% formalin
for 20 min and washed three times in PBS + 1% BSA. The
cells were then permeabilized and blocked with PBS con-
taining 0.3% Triton X-100, 1% BSA and 10% universal
blocking reagent. After blocking, the cells were incubated
overnight at 4 °C with an antibody (PA5-30591; Fisher Sci-
entific) against fatty acid binding protein 4 (FABP4). The
cells were then washed three times in PBS + 1% BSA, in-
cubated for 60 min in the dark with a secondary antibody
coupled to Alexa Fluor 488 (A-11008; Fisher Scientific),
washed three times in PBS + 1% BSA and visualized under
an epifluorescence microscope (Zeiss Axiovert S100; Carl
Zeiss, Oberkochen, Germany).
In order to stain the cells with Bodipy, the cell
medium was removed and the cells were incubated for 1
h with a fresh medium containing 100 μg/ml of Bodipy
(Molecular Probes, Fisher Scientific), washed and imaged
under the epifluorescence microscope.
MAP2 and cresyl violet staining
To assess neurogenic differentiation, cells were fixed and
incubated with microtubule-associated protein 2 (MAP2)
antibody (reference 4542; Cell signaling, Saint Quentin,
France) following the same protocol as for the FABP4
antibody (see earlier).
In order to stain Nissl bodies, cells were washed and
fixed with 10% formalin for 20 min. Then a 0.5% cresyl
violet staining solution (Sigma Aldrich) was added to
cells and incubated for 30 min at room temperature.
The cells were then washed three times in PBS and im-
aged under an epifluorescence microscope.
Living cell imaging
haMSCs were seeded, prior to the differentiation, on a
glass-bottom, four-well μ-slide (reference 80,447; Ibidi
GMBH, Planegg, Germany). Prior to confocal imaging,
cells were incubated for 30 min with 375 nM Hoechst
33342 (nuclei marker; λexc = 480 nm, λem = 535 nm)
and 5 μM of fluorescein diacetate (FDA) (cytoplasm
marker; λexc = 405 nm, λem = 486 nm). A confocal
microscope Leica TCS SPE with an objective HC PL
APO CS2 20× and LAS AF software version 3.3 (Leica,
Germany) were used to visualize the mono/multilayers
in osteogenic, adipogenic or neurogenic differentiation.
Calcium oscillation visualization and analysis
The upper layers in osteogenic differentiation were dis-
sociated by collagenase I as already described, the lowest
layer was trypsinized and the cells from each layer type
were seeded apart at a density of 15,000 cells/cm2 for
24 h in an osteogenic differentiation medium. After
24 h, the medium was removed and the cells were incu-
bated for 30 min with 5 μM of Fluo-4 AM (Fischer Sci-
entific), a fluorescent Ca2+ marker, in a humidified 5%
CO2 atmosphere at 37 °C in osteogenic medium. The
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incubation buffer also contained 375 nM of the nuclear
fluorescent dye Hoechst 33342. After incubation, the at-
tached cells were rinsed three times with PBS and 500 μl
of fresh medium was added to the cells. Images of the
cells were then taken every 10 s for 30 min under a
fluorescence microscope (Zeiss Axiovert 100 with a
Zeiss AxioCam Hrc camera controlled by Axio Vision
4.6 software; Carl Zeiss). The excitation and emission
wavelengths used for Fluo-4 were 496 nm and 515 nm
respectively. The nuclear dye Hoechst 33342 (λex =
350 nm, λem = 461 nm) was used to facilitate cell identi-
fication and calcium oscillation determination using Cell
Profiler (version 2.0) software (Broad Institute, Cam-
bridge, MA, USA).
Immunofluorescent staining
Upper layers in osteogenic differentiation were dissoci-
ated with 2 mg/ml of collagenase I. The remaining layer
was trypsinized. On day 22, the differentiating cell cul-
tures were treated first by 20 mM EDTA in PBS before
collagenase addition. Cells were counted and centrifuged
at 825 rpm for 10 min, after which the supernatant was
aspirated and the cells were suspended in a buffer of
PBS, 0.5% BSA and 2 mM EDTA (100 μl/100,000 cells).
Then 10 μl of anti-CD44 APC, CD90 PE and CD105
FITC was added per 100 μl of cells. The cells were incu-
bated with the antibodies for 10 min at 4 °C in the dark.
The cells were then washed with 1 ml of buffer and cen-
trifuged. The pellet was resuspended in 300 μl of buffer
for analysis by flow cytometry (Accuri C6 cytometer; BD
Life Sciences, Le Pont de Claix, France). The antibodies
were purchased from Miltenyi Biotec (Paris, France).
Statistical analysis
To compare the differences in alkaline phosphatase
activity during osteogenesis (Fig. 1), one-way ANOVA
with Tukey’s multiple comparisons test was used. To
compare the difference in immunofluorescent staining
between the upper and lowest layers (Fig. 5a), an un-
paired t test was used. To analyze the influence of the
layers and the number of days of differentiation on
Ca2+ oscillations (Fig. 5b), two-way ANOVA with
Tukey’s multiple comparisons test was used. To com-
pare the control to the other conditions, we used
one-way ANOVA with Dunnett’s multiple compari-
sons test. All results are expressed as the mean and
Fig. 1 haMSC differentiation. a–-d Morphological aspects of the cells. (a) Control haMSCs (grown in classical MSC culture medium) after 3 days of
culture. (b), (c), (d) haMSCs undergoing respectively osteogenic (day 29), adipogenic (day 15) and neurogenic (day 5) differentiation. e, f
Osteogenic differentiation characterized by Alizarin Red staining (e) and alkaline phosphatase activity (f). g, h Adipogenic differentiation
characterized by labeling with FABP4 antibody (g) and bodipy staining (h). i, j Neurogenic differentiation characterized by cresyl violet staining (i)
and labeling with MAP2 antibody and Hoechst (j). In (e, g–j), right photograph displays background staining of undifferentiated control haMSCs
cultured in classical growth medium. Calibration bars correspond to 100 μm. ****p < 0.0001, ***p < 0.001, **p < 0.01, *p < 0.05. pNP
p-nitrophenol, MSC mesenchymal stem cell
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standard deviation from three different differentia-
tions. These three differentiations were performed
using cells from three different donors.
Results
Characterization of cell differentiation
Before analyzing the layers formed in various haMSC differ-
entiations, we first confirmed that the cells had undergone
every differentiation correctly. Characterization of osteodif-
ferentiation was performed by the measurement of ALP ac-
tivity and the staining of Ca2+ deposits using Alizarin Red.
The undifferentiated control haMSCs (Fig. 1a) were cul-
tured in classical MSC growth medium and displayed no
Alizarin Red labeling and no ALP activity (Fig. 1e right, f).
In osteogenic differentiation, the Ca2+ deposits started to
accumulate at the end of the second week and became
more and more dense (Fig. 1b). These deposits were col-
ored red by the Alizarin Red staining (Fig. 1e left). The ALP
activity slightly increased at day 8 of osteodifferentiation
and reached a peak on day 15 (Fig. 1f).
The adipodifferentiation was characterized by FABP4
staining and lipidic vacuole formation. The lipidic vacu-
oles shown in Fig. 1c are stained green by Bodipy staining
(Fig. 1h left). The adipose cells fluoresced in green after
FABP4 labeling (Fig. 1g left). The undifferentiated haMSC
controls (cultured in classical MSC growth medium) dis-
played no Bodipy staining (Fig. 1h right) or FABP4 anti-
body labeling (Fig. 1g right). The cresyl violet that stains
the Nissl bodies specific of the neuronal differentiation
(Fig. 1d) labeled the haMSCs undergoing neurodifferentia-
tion (Fig. 1i left) but not the undifferentiated haMSC con-
trols (Fig. 1i right). The MAP2 antibody interacted with
neuronal cells but not with undifferentiated haMSC con-
trols, and this was revealed by the green fluorescence dis-
played by the neuronal cells (Fig. 1j).
Evolution of the cell number in the different
differentiation pathways
To better understand the various numbers of cell
layers observed between the different differentiation
pathways, the kinetics of cell proliferation were
assessed. When the cells were exposed to the neuro-
differentiation medium, they showed no proliferation
at all: the cell number remained nearly the same dur-
ing all of the differentiation process (Fig. 2). In adipo-
genic differentiation, cell proliferation was maintained,
only slightly reduced with respect to the proliferation
in the controls (Fig. 2). On the contrary, in osteogenic
differentiation there was a real stimulation of the cell
proliferation: cells proliferated extensively between
day 1 and 15 and faster than the control haMSCs
(Fig. 2). At days 8 and 15, there were nearly four and
six times more cells than at day 1. After day 15, no
further increase of the cell number was observed.
In osteogenic differentiation, due to the initial very
rapid cell proliferation, cells started to accumulate in
several layers in the first week of osteodifferentiation.
The number of layers stabilized at the end of the second
week when the cells stopped proliferation. Four different
layers of cells could be detected using confocal micros-
copy on day 22 of osteodifferentiation, every layer hiding
the previous one (Fig. 3d). The layers were well sepa-
rated, and almost no cell could be observed in between.
In adipogenic differentiation (Fig. 3c), above a first con-
tinuous layer, a discontinuous second layer of cells could
also be observed in some parts of the dish. In neuro-
genic differentiation, even at day 22, cells always
remained in one single layer (Fig. 3b) in agreement with
the total absence of cell proliferation (Fig. 2). Further-
more, the cells shrank with time when they transformed
from the mesenchymal fibroblastic shape to the neur-
onal one.
Characterization of the different cell layers in osteogenic
differentiation
When classical trypsinization (incubation of up to
10 min) was performed on the cells undergoing
osteogenic differentiation, trypsin had absolutely no
effect. It was only after more than 30 min of incuba-
tion with trypsin that all of the layers started to de-
tach altogether as a whole surface (like a rolled-up
carpet) with all of the layers still attached together,
not detaching as individual cells or individual layers.
This means that trypsin is only able to remove the
connections between the bottom layer and the cul-
ture dish, not the connections between layers or the
connections between cells within a given layer. On
the contrary, when 2 mg/ml collagenase I was ap-
plied to the cells undergoing an osteogenic differen-
tiation, the bottom cells remained attached to the
culture dish and all of the cells from the upper
layers were individually dissociated (not as whole in-
tact layers). This demonstrates that collagenase I
only removed interactions between individual cells
but not the connections between the bottom cells
and the culture dish. Moreover, after the action of
collagenase I, only the bottom layer remained at-
tached (Fig. 4a right). This lowest layer was not sen-
sitive to collagenase. It could only be detached by
trypsin. Therefore, collagenase I was able to select-
ively detach all of the cells from the upper layers
but not those from the bottom layer, and trypsin
was doing the exact opposite.
When the mineralization occurred, collagenase I had
no effect at all, even on the upper layers. The Ca2+ de-
posits had to be removed first. Prior EDTA treatment
(20–40 mM for 20–40 min) was used to remove these
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deposits and the collagenase concentration had to be in-
creased from 2 to 4 mg/ml (Fig. 4b).
The upper (collagenase sensitive) and lowest (trypsin
sensitive) layers were labeled using MSC markers at days
1, 8, 15 and 22 (Fig. 5a). As expected, the cells significantly
lost the MSC markers (CD105, CD90 and CD44) when
they progressed in the differentiation (p < 0.0001, two-way
ANOVA). Unexpectedly, this immunostaining showed dif-
ferent evolutions between the upper and the lowest layers.
The CD105 expression was the most rapidly lost among
the three. At day 8, 60% of the cells had already signifi-
cantly lost it (p < 0.0001, two-way ANOVA with Tukey’s
multiple comparisons test). At day 22, only 15–20% of the
cells were still positive for CD105 labeling. No significant
differences between the upper and lowest layers were ob-
served in terms of CD105 labeling (p = 0.7081, p = 0.8878
and p = 0.7531 at days 8, 15 and 22, two-way ANOVA
with Tukey’s multiple comparisons test). The loss of the
CD90 and CD44 positive labeling was slower and more
progressive (Fig. 5a). Moreover, a different evolution was
found in the cells from the upper and lowest layers. The
decrease was significantly faster in the trypsin-treated cells
(lowest layer) than in the collagen-treated cells (upper
layers) (p < 0.05 to p < 0.001, two-way ANOVA with
Tukey’s multiple comparisons test), except for day 8 for
CD44 (p = 0.8376, two-way ANOVA with Tukey’s multiple
Fig. 2 Evolution of cell number between day 1 and day 29 in different groups of cells. Controls are undifferentiated haMSCs cultured in classical
growth medium. Ctrl control, Neuro neurogenic, Adipo adipogenic, Osteo osteogenic
Fig. 3 a Schematic representation of different layers of differentiation observed using confocal microscopy. Different layers of neurogenic (b),
adipogenic (c) and osteogenic (d) differentiation. Confocal observation at day 22, stained with Hoechst and fluorescein diacetate. For each
differentiation, panels represent (from left to right) bottom layer (L1, layer in contact with the coverslide), second (L2), third (L3) and fourth (L4)
layer, respectively. Grids below represent position of confocal slice on Z axis. Calibration bars correspond to 50 μm. Neuro neurogenic, Adipo
adipogenic, Osteo osteogenic
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comparisons test). The cells in the controls expressed
their markers at high levels all of the time.
The different layers were also compared in terms of cyto-
solic Ca2+ oscillations. Indeed, it was shown that the fre-
quency of spontaneous Ca2+ oscillations in MSCs decreases
rapidly with osteodifferentiation to the level observed in
terminally differentiated human osteoblasts [27]. Therefore,
the Ca2+ oscillation frequency was studied for the different
cell layers in order to compare their osteogenic level of dif-
ferentiation. These oscillations significantly decreased when
Fig. 4 Action of collagenase I and EDTA on osteogenic layers. a Observation of cells before (left) and after (right) action of collagenase I (2 mg/
ml) on day 15 of osteodifferentiation. b Ca2+ deposits before (left) and after (right) action of 40 mM of EDTA on day 29 of osteodifferentiation.
Calibration bars correspond to 100 μm
Fig. 5 a Immunostaining of upper and lowest layers in osteogenic differentiation. b Comparison of number of Ca2+ oscillations between upper
and lowest layers on different days of osteogenic differentiation. haMSC controls (undifferentiated haMSCs grown in classical MSC culture
medium) have significantly more Ca2+ oscillations than differentiated layers (****p < 0.0001, one-way ANOVA with Dunnett’s multiple comparisons
test). At day 8, Ca2+ oscillations were significantly lower in number in lowest layer than in upper layers (**p < 0.01, p = 0. 0038, two-way ANOVA
with Sidak’s multiple comparisons test). Whiskers represent 95th and 5th percentiles. Ctrl control, tryps lowest layer trypsinized, Coll upper layers
dissociated with collagenase I, MSC mesenchymal stem cell
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the haMSCs were put in the osteodifferentiation medium
(p < 0.0001, one-way ANOVA with Dunnett’s multiple
comparisons test) (difference between haMSCs and
cells under differentiation shown in Fig. 5b). At all of
the days observed, the mean Ca2+ oscillations were lower
in number (per 30 min) in the lowest layer than in the
upper layers, even though this is only significant at day 8
(p < 0.01, p = 0.0038, two-way ANOVA with Sidak’s mul-
tiple comparisons test).
At day 15, cells from the upper layers (dissociated by
collagenase) and the lowest layer (dissociated by trypsin)
were put in culture separately in osteogenic medium.
Both cell types recovered cell proliferation (Additional
file 1: Figure S1), and after 2 weeks they formed two or
three of cells with Ca2+ deposits (data not shown). The
mineralization is less important in the cells differentiated
from the lowest layer (Fig. 6a) than in the cells differen-
tiated from the upper layers (Fig. 6b) (Additional file 2:
Figure S2). The cells of the upper and lowest layers
placed in culture with a normal medium (without
osteoinductive factors) did not form Ca2+ deposits (data
not shown).
Discussion
Existence of distinct layers in haMSC osteogenic
differentiation
In our study, we performed for the first time a sequen-
tial treatment to dissociate haMSCs undergoing osteo-
genic differentiation in 2D in-vitro cultures, first using
collagenase I and then trypsin. Collagenase I is used to
dissociate cells from rodent or human bones in order
to obtain primary osteoblasts [28, 29]. Collagenase I,
at a high concentration (20 mg/ml) and with agitation
at 37 °C, is also used in 3D cultures in vitro, for ex-
ample to harvest cells from microcarrier cultures [25].
Collagenase B was also reported to dissolve collagen
scaffolds in in-vitro 3D cultures [24]. In the work re-
ported here, haMSCs were differentiated into osteo-
blasts. The multipotency of these cells was also
assessed by their ability to differentiate into adipocytes
and neuronal cells (as shown in Fig. 1). The use of col-
lagenase I did not dissociate all of the cells in the
osteogenic differentiation since a cell layer remained
attached to the bottom of the dish as shown in Fig. 4.
To the best of our knowledge, only a single study by
Franceschi et al. [30] mentioned a “remaining layer”.
They used 0.15 M phosphate buffer containing 2 mM
phenylmethylsulfonylfluoride and 2.5 m M N-ethylma-
leimide to dissociate the cells (until day 7 of osteodif-
ferentiation). After that, they collected the cells of the
remaining layer separately. The remaining layer in our
case had to be trypsinized. Our results demonstrate
that there are two types of layers in osteogenic differ-
entiation that have not been explored previously: the
upper layers which are collagenase I sensitive; and the
lowest layer, attached to the substrate, which is trypsin
sensitive only. It must be noted that in our experi-
ments the use of trypsin only (until day 15) showed an
effect on all of the layers and detached all of the cells,
but the cells were not as well dissociated as with the
collagenase I (data not shown). We will thus refer to
the upper layers as the collagenase-sensitive layers and
to the lowest layer as a trypsin-sensitive layer.
As described in Results, at day 22 the cells formed
four layers in osteogenic differentiation, one layer in
neurogenic differentiation and two layers, one
continuous and one discontinuous, in adipogenic dif-
ferentiation. Thus, only the cells in osteogenic differ-
entiation form several continuous layers. These
differences in the number of cell layers cannot be
solely attributed to the presence of ascorbic acid in
the osteogenic medium and its role in extracellular
matrix synthesis. Indeed, the adipogenic differenti-
ation (achieved in the absence of ascorbic acid) gener-
ated two cell layers. On the other hand, these
observations correlate perfectly with the evolution of
the cell number, since the cells proliferated massively
for the first 15 days in osteogenic differentiation and
this proliferation was higher than in the adipogenic
and neurogenic differentiations. After day 15, we
Fig. 6 Cells from lowest (a) and upper (b) layers dissociated on day 15 and put in osteogenic medium for 2 weeks. Black spots, Ca2+ deposits.
Calibration bars correspond to 100 μm
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observed no further proliferation of the cells as well as
the beginning of the mineralization. The evolution of
the cell number in osteogenic differentiation corrobo-
rates the observations in other studies showing also
that cell proliferation stops by the second week of the
osteogenic differentiation [3]. Cells have to proliferate
before mineralization in order to increase bone mass.
After mineralization started, the action of collagenase I
was more difficult. This is why we first treated the cells
with 20 mM EDTA to remove the Ca2+ deposits. EDTA
is classically used during osteoblast isolation from ro-
dent and human bones [28]. EDTA is also used in vitro
on fixed cells in order to remove Ca2+ deposits [9] or
combined with trypsin for harvesting cells in osteogenic
differentiation [24, 25]. However, the EDTA concentra-
tions used in vitro on fixed cells (about 350 mM) were
9–17 times higher than the concentrations we used here
on viable cells [9]. The dissociation of the upper and
lowest layers on day 29 required a higher EDTA concen-
tration (40 mM) and a longer treatment time (40 min).
After this intense EDTA treatment, collagenase I dissoci-
ated and detached all of the cells from the dish, probably
because EDTA weakened the bonds between the lowest
layer and the bottom of the dish due to the chelation of
the Ca2+ necessary to keep the cells attached to the cul-
ture substrate.
Differences between upper and lowest layers
The upper and lowest layers were characterized by clus-
ter of differentiation (CD) expression and by Ca2+ oscil-
lations. The MSCs express CD105, CD90 and CD44
when they are multipotent [31, 32]. As the cells progress
in the differentiation process, they lose the multipotency
markers compared to the control cells. The two types of
layers showed no difference in losing the CD105 expres-
sion but showed a difference in the CD90 and CD44
evolution. This observation reveals that the cells in the
two layers are not identical. Since the decrease was
probably faster in the cells of the upper layer, these latter
could be considered more differentiated than the cells of
the lowest layer. The determination of the number of
spontaneous Ca2+ oscillations during a given period of
time confirmed previous results showing that the fre-
quency of Ca2+ oscillations decreases progressively when
MSCs undergo the osteogenic differentiation [27]. It also
revealed, again, that cells of the two layers behave differ-
ently. On day 8 of osteodifferentiation, the Ca2+ oscilla-
tion frequency was lower in the lowest layer than in the
upper layers, which could indicate that the cells of the
lowest layer could differentiate faster than the cells of
the upper layer. However, no significant difference was
observed on days 15 and 22.
To further investigate the osteogenic potential of the
two layer types, cells from the upper layers and cells from
the lowest layer were taken at day 15 and separately put
again in the osteogenic medium at the same confluency as
at day 1 of osteodifferentiation. Cell growth resumed and
after 2 weeks cells had again formed multilayers as well as
Ca2+ deposits. The Ca2+ deposits were more extensive in
the cells from the upper layers. Moreover, the cells origi-
nated from lowest layer proliferated more extensively than
the cells originated from the upper layers. Three conclu-
sions can be drawn from this experiment: the first is that
the cells, even on day 15, could proliferate again provide
they are separated and cultured again. It is true that they
did not form four layers as in the first 2 weeks of osteodif-
ferentiation but they still formed two or three layers of
cells, repetitively. On the contrary, if the layers had
remained together, they would have stopped proliferation
at day 15 (Fig. 2). The second conclusion is that this ex-
periment confirmed our previous observations showing
that the two cell layer types are different. The upper layers
are slightly more differentiated than the lowest one. In-
deed, the former cells proliferated less than the cells origi-
nated from the lowest layer and they produced more Ca2+
deposits after a further 2 weeks. The cells located in the
upper layers are embedded in the collagen matrix that
they produce, which could facilitate their osteogenic dif-
ferentiation [33]. Therefore, the use of collagen-coated
plates might reduce the differences observed between the
upper and lower layers. However, access to oxygen and to
the differentiation factors present in the medium might
also be limited in the lower layer, which could also con-
tribute to their lower differentiation. Finally, the very im-
portant role of the osteogenic extracellular matrix is
confirmed. As mentioned previously, osteoblasts must be
in contact with such a matrix to differentiate [4, 14, 34].
When cells were dissociated and separated from the extra-
cellular matrix, as in our case, the cells again presented an
ability to proliferate.
Conclusions
We show that haMSCs undergoing osteogenic differentiation
form several layers. Collagenase I was used to dissociate the
cells of the upper layers, which gives access to a lowest at-
tached layer sensitive to trypsin. The collagenase-sensitive
upper layers and the trypsin-sensitive lowest layer showed
differences in the expression of the haMSC CDs. The
characterization of these two types of layers that are not
identical constitutes a new observation in osteogenic differ-
entiation which offers new possibilities in the control of the
number, the quality and the time to produce terminally dif-
ferentiated osteoblasts. We can suggest that the investigators
could indeed, on the one hand, dissociate the upper layers by
collagenase I on day 15, expand them and use them rapidly
(in 15 days) as terminally differentiated osteoblasts; and on
the other hand, treat the lowest layer with trypsin and again
put the cells in culture to keep them in proliferation, to
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dissociate them later and to continue the cycle of the pro-
duction of differentiated osteoblast in only 2 weeks (instead
of 4 weeks) from a pool of rapidly growing cells in the mid-
dle of the differentiation process. This cycle should favor
both the production of differentiated osteoblasts and the
maintenance of a stock of cells undergoing the differentiation
facilitating the application of these cells and spreading their
uses.
Additional files
Additional file 1: Figure S1. Cell growth in osteodifferentiation
medium for three consecutive periods of 15 days. Culture dishes always
seeded with same number of cells at day 1 and cells counted after
15 days of culture. Growth reported as increase fold in number of cells at
day 15. haMSCs cultured in osteodifferentiation medium for “first
differentiation”. After 15 days, upper layers (U1) and lowest layer (L1)
were counted and seeded separately in osteodifferentiation medium
(“second differentiation”). After 15 more days, upper layers (U2 from U1
and U2 from L1) and lowest layer (L2 from U1 and L2 from L1) were
counted and seeded separately in osteodifferentiation medium (“third
differentiation”). After 15 days, all cells were counted for each condition
(U2(U1), U2(L1), L2(U1) and L2(L1)). Each condition counted three times
in three independent repeats. Diff differentiation. (TIF 117 kb)
Additional file 2: Figure S2. Quantification of Alizarin Red staining
in upper and lowest layers. haMSCs were cultured in
osteodifferentiation medium for “first differentiation”. After 15 days,
upper layers (U1) and lowest layer (L1) were seeded separately in
osteodifferentiation medium (“second differentiation”). After 15 more
days, upper layers (U2 from U1 and U2 from L1) and lowest layer (L2
from U1 and L2 from L1) were seeded separately in
osteodifferentiation medium (“third differentiation”). After 15 days, for
each condition (U2(U1), U2(L1), L2(U1) and L2(L1)), deposits of
calcium phosphate were stained with Alizarin Red and quantified by
elution of stain using cetylperidinium chloride and quantification by
spectrophotometry. Results normalized by number of cells. Each
condition quantified three times in three independent repeats. (TIF
125 kb)
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